Explore our collection of health and pharma advertising resources.
During my years on the agency side, understanding segmentation for patient audiences was one of my favorite parts of planning campaigns. We’d get personas from the brand that looked something like this. Mary, who is 35 to 54 years old, has Rheumatoid Arthritis and enjoys birdwatching. But because agencies generally don’t have access to claims […]
Programmatic campaigns conducted on the DeepIntent platform are now guaranteed to reach verified patient audiences for specific health conditions across CTV, display, and digital video NEW YORK, May 3, 2022 — DeepIntent, the leading healthcare advertising technology company built to influence patient health and business outcomes, announced today it will now offer guarantees on the […]
A particularly hot topic at the moment, privacy is a core pillar of healthcare advertising. It is important for both pharma marketers and consumers to know that any health data is both well-protected and in the right hands. Thankfully for pharma marketers — who are already required to follow stringent regulations like HIPAA — there […]
Learn more about your audience in real time with DeepIntent Outcomes. Fully understand patient profiles based on script performance to improve your overall strategy and tactics. Download Now
Efficiently marketing to sufferers of rare diseases while preserving patient privacy is not an easy task — but it’s an important one, especially when lives are on the line. Take hereditary angioedema (HAE), for example. Most people have not heard of this condition; only one in 66,000 people has it. Living with HAE is a […]
DeepIntent’s Patient Modeled Audiences Solution Uses Industry’s Most Comprehensive Real-World Clinical Datasets to Precisely Reach Patient Populations, Including Those Facing Rare Diseases and Low Prevalence Conditions NEW YORK, Jan. 11, 2022 — DeepIntent, the leading healthcare advertising technology company built to influence patient health and business outcomes, today announced that the United States Patent and […]
Artificial intelligence and machine learning technology are revolutionizing the healthcare industry right before our very eyes. In this article for AiThority.com, CEO Chris Paquette writes about the impact of more personalized, data-driven marketing on patient outcomes. Read more here.
Even as advertising technology gets more intelligent, more data-driven, and more automated, achieving ad relevance is no easy task. It can be especially challenging for pharmaceutical companies looking to reach patients who might be in the market for a certain drug or treatment. When it comes to pharmaceutical ads, personalizing the connection with patients and […]
DeepIntent surveyed 1,244 U.S. patients in August 2021 about their attitudes toward pharmaceutical ads and whether they find them relevant. In this article, Pharmaceutical Executive Magazine shares key takeaways from the survey revealing how advertising motivates patients to research their treatment and medication options. DeepIntent’s CEO Chris Paquette also shares the opportunities healthcare marketers can […]
Sign up for the newsletter to ensure our latest whitepapers, research reports, and more are delivered to your inbox.
